Estrogen Receptor Positive Tumor

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer

OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk

PRE-I-SPY Phase I/Ib Oncology Platform Program

Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer

To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)

Characterization of Biophysical and Mechanical Parameters on Skin of Breast Cancer Patients

A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer

Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression

ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer

Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast Cancer

Dalpiciclib in Combination With Exemestane and Trastuzumab Plus Pyrotinib in Early Triple Positive Breast Cancer

Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases

The MASTER Study (MAmmary Cancer STatin ER Positive Study)

Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant Exposure

Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast Cancer

Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women

A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast Cancer